Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20630743 | 0.95 | LMNA (0.56) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL1189940 | 0.87 | CA5A (0.64) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL12020820 | 0.87 | LMNA (0.48) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL5682878 | 0.87 | CA1 (0.52) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL20239499 | 0.86 | KMT2A (0.54) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL11532780 | 0.86 | ABCG2 (0.49) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL25061973 | 0.85 | LMNA (0.47) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL1765000 | 0.85 | LMNA (0.47) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL11264625 | 0.85 | CA1 (0.53) | MAPK1MEN1KMT2AL3MBTL1LMNA | |
| SCHEMBL1189073 | 0.85 | LMNA (0.47) | MAPK1MEN1KMT2AL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 443 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574113-A | Synthesis method of natural molecule 5- (4-hydroxy benzofuran-2-yl) benzene-1, 3-diphenol | 江苏集萃分子工程研究院有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | claimed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118026859-A | Preparation method of terbutaline | 南京法恩化学有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-116606499-A | Polyethylene/nano composite thin-wall direct-current cable material for inhibiting space charge and preparation method thereof | 西安交通大学 | 2023-08-18 | — | — | CN | claimed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | claimed |
| CN-113663463-B | Odor inhibitor | 日东生物科技(浙江)有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-112209841-B | Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate | 扬州中宝药业股份有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-113663463-A | Odor inhibitor | 日东生物科技(浙江)有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-112209841-A | Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate | 扬州中宝药业股份有限公司 | 2021-01-12 | — | — | CN | claimed |
| CN-104974135-B | Targeting DNA has the Sai-Mi-Xi-Bu derivative containing benzene-naphthalene diimide structure of antitumor activity, pharmaceutical composition and its preparation method and application | 河北大学 | 2017-03-08 | — | — | CN | claimed |
| CN-101665418-B | Methods for preparing E-3,5-dimethoxy-4'-oxhydryl diphenylethene and derivative thereof | GUANGZHOU INST OF CHEMISTRY | 2012-11-28 | — | — | CN | claimed |
| CN-101665419-B | Method for preparing (Z)-3'-hydroxy-3,4',5-trimethoxy diphenylethene | GUANGZHOU INST OF CHEMISTRY | 2012-10-03 | — | — | CN | claimed |
| CN-101665418-A | Methods for preparing E-3,5-dimethoxy-4'-oxhydryl diphenylethene and derivative thereof | GUANGZHOU INST OF CHEMISTRY | 2010-03-10 | — | — | CN | claimed |
| CN-101665419-A | Method for preparing (Z)-3'-hydroxy-3,4',5-trimethoxy diphenylethene | GUANGZHOU INST OF CHEMISTRY | 2010-03-10 | — | — | CN | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| JP-7206642-A | — | — | None | — | — | JP | disclosed |
| CN-121574113-B | Synthesis method of natural molecule 5- (4-hydroxy benzofuran-2-yl) benzene-1, 3-diphenol | 江苏集萃分子工程研究院有限公司 | 2026-04-21 | — | — | CN | disclosed |
| CN-121574113-A | Synthesis method of natural molecule 5- (4-hydroxy benzofuran-2-yl) benzene-1, 3-diphenol | 江苏集萃分子工程研究院有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-121574113-A | Synthesis method of natural molecule 5- (4-hydroxy benzofuran-2-yl) benzene-1, 3-diphenol | 江苏集萃分子工程研究院有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-20260055062-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2026-02-26 | — | — | US | disclosed |
| CN-121181407-A | Synthesis method of cycloheximide key intermediate | 浙江大学 | 2025-12-23 | — | — | CN | disclosed |
| US-12492171-B2 | Heterocyclic inhibitors of MCT4 | Vettore, LLC (US) | 2025-12-09 | — | — | US | disclosed |
| CN-120097816-A | Preparation method and application of alkoxy substituted chalcone derivative | 深圳大学 | 2025-06-06 | — | — | CN | disclosed |
| CN-119954875-A | Preparation method of acetylated anthocyanin monomer | 广东工业大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-119899810-A | Imine reductase mutant and application thereof in synthesis of chiral 1, 3-disubstituted tetrahydroisoquinoline | 江南大学 | 2025-04-29 | — | — | CN | disclosed |
| CN-119736228-A | Method for synthesizing chiral 1, 3-disubstituted tetrahydroisoquinoline by using chemical enzyme cascade system | 江南大学 | 2025-04-01 | — | — | CN | disclosed |
| US-20250033082-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2025-01-30 | — | — | US | disclosed |
| WO-2025023252-A1 | ANTIOXIDANT COMPOUND | 国立大学法人 大分大学 | 2025-01-30 | — | — | WO | disclosed |
| CN-118930421-A | Deuterated or fluoroindenone TNF-alpha inhibitor and preparation method and application thereof | 江苏安杰泰生物科技有限公司 | 2024-11-12 | — | — | CN | disclosed |
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| EP-4442318-A2 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-4423178-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2024-09-04 | — | — | EP | disclosed |
| CN-118546054-A | Method for preparing alpha-deuterated ketone compound by photocatalysis and application thereof | 武汉大学 | 2024-08-27 | — | — | CN | disclosed |
| WO-2024159284-A1 | NAV1.7- AND/OR NAV1.8-INHIBITING HYDRAZIDES, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | EUROFARMA LABORATÓRIOS S.A. (BR) | 2024-08-08 | — | — | WO | disclosed |
| CN-114890947-B | Aromatic heterocyclic compound containing quinoline structural unit, and preparation method and application thereof | 郑州大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-118184558-A | Thiophenylamide compound, and preparation method and application thereof | 五邑大学 | 2024-06-14 | — | — | CN | disclosed |
| EP-3551625-B1 | HETEROCYCLIC INHIBITORS OF MCT4 | VETTORE LLC (US) | 2024-06-12 | — | — | EP | disclosed |
| US-11987506-B2 | Salt recovery solution and processes of use thereof | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-05-21 | — | — | US | disclosed |
| CN-118026859-A | Preparation method of terbutaline | 南京法恩化学有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-118026859-A | Preparation method of terbutaline | 南京法恩化学有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20240107872-A1 | Metal complexes | UDC IRELAND LIMITED (IE) | 2024-03-28 | — | — | US | disclosed |
| CN-117511579-A | Biomass pyrolysis method and device | 华陆工程科技有限责任公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117466943-A | metal complex | UDC爱尔兰有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-117323372-A | Zanthoxylum bungeanum leaf essential oil microemulsion and preparation method and application thereof | 青海民族大学 | 2024-01-02 | — | — | CN | disclosed |
| CN-112218849-B | Process for the preparation of amines | 巴斯夫欧洲公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116606499-A | Polyethylene/nano composite thin-wall direct-current cable material for inhibiting space charge and preparation method thereof | 西安交通大学 | 2023-08-18 | — | — | CN | disclosed |
| US-20230257284-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-08-17 | — | — | US | disclosed |
| CN-116282078-A | Salt recovery solution and method of using the same | 阿克福特斯技术有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023073536-A1 | METHOD AND COMPOSITION FOR REDUCING SOLVENT RELEASE FROM, AND REDUCING ODOR OF, AGROCHEMICAL FORMULATIONS | ADAMA MAKHTESHIM LTD. (IL) | 2023-05-04 | — | — | WO | disclosed |
| CN-111225875-B | Salt recovery solution and method of using salt recovery solution | 阿克福特斯技术有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20230043356-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-02-09 | — | — | US | disclosed |
| US-20230025575-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2023-01-26 | — | — | US | disclosed |
| EP-4069418-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2022-10-12 | — | — | EP | disclosed |
| CN-110114351-B | Heterocyclic inhibitors of MCT4 | 维托尔股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-114890947-A | Aromatic heterocyclic compound containing quinoline structural unit and preparation method and application thereof | 郑州大学 | 2022-08-12 | — | — | CN | disclosed |
| US-20220251047-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2022-08-11 | — | — | US | disclosed |
| CN-113663463-B | Odor inhibitor | 日东生物科技(浙江)有限公司 | 2022-08-02 | — | — | CN | disclosed |
| US-11390578-B2 | Method for synthesizing amines | BASF SE (DE) | 2022-07-19 | — | — | US | disclosed |
| CN-114746179-A | Method for producing amines on copper catalysts | 巴斯夫欧洲公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-109952290-B | FGFR4 inhibitor and preparation method and application thereof | 广东众生药业股份有限公司 | 2022-05-03 | — | — | CN | disclosed |
| US-11292767-B2 | Heterocyclic inhibitors of MCT4 | Vettore, LLC (US) | 2022-04-05 | — | — | US | disclosed |
| EP-3774716-B1 | PROCESS FOR THE PREPARATION OF AMINES | BASF SE (DE) | 2022-03-16 | — | — | EP | disclosed |
| CN-112209841-B | Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate | 扬州中宝药业股份有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-112209841-B | Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate | 扬州中宝药业股份有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-109745325-B | FGFR4 inhibitor, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2022-02-15 | — | — | CN | disclosed |
| EP-3946712-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR | Aquafortus Technologies Limited (NZ) | 2022-02-09 | — | — | EP | disclosed |
| US-11236113-B2 | Hydrocarbon-soluble halogen and thiolate/magnesium exchange reagents | ALBEMARLE GERMANY GMBH (DE) | 2022-02-01 | — | — | US | disclosed |
| CN-113891760-A | Solvent drying compositions and related methods | 阿克福特斯技术有限公司 | 2022-01-04 | — | — | CN | disclosed |
| CN-107922585-B | Low emission epoxy resin composition | SIKA技术股份公司 | 2021-11-23 | — | — | CN | disclosed |
| CN-113663463-A | Odor inhibitor | 日东生物科技(浙江)有限公司 | 2021-11-19 | — | — | CN | disclosed |
| WO-2021219664-A1 | ANTI-BACTERIAL AND ANTI-VIRAL COMPOUNDS | UNIVERSITÉ DE GENÈVE (CH) | 2021-11-04 | — | — | WO | disclosed |
| US-20210301075-A1 | LOW-EMISSION EPOXY RESIN COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2021-09-30 | — | — | US | disclosed |
| US-20210277175-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2021-09-09 | — | — | US | disclosed |
| CN-113321586-A | Low emission epoxy resin composition | SIKA技术股份公司 | 2021-08-31 | — | — | CN | disclosed |
| US-11046809-B2 | Amine for low-emission epoxy resin compositions | SIKA TECHNOLOGY AG (CH) | 2021-06-29 | — | — | US | disclosed |
| WO-2021110472-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2021-06-10 | — | — | WO | disclosed |
| US-20210155574-A1 | METHOD FOR SYNTHESIZING AMINES | BASF SE (DE) | 2021-05-27 | — | — | US | disclosed |
| US-11008292-B2 | FGFR4 inhibitor and preparation method and use thereof | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) | 2021-05-18 | — | — | US | disclosed |
| US-11008292-B2 | FGFR4 inhibitor and preparation method and use thereof | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) | 2021-05-18 | — | — | US | disclosed |
| WO-2021085321-A1 | RESIN COMPOSITION, RESIN SHEET, CURED FILM, METHOD FOR MANUFACTURING CURED FILM, SEMICONDUCTOR DEVICE, ORGANIC EL DISPLAY DEVICE, AND DISPLAY DEVICE | 東レ株式会社 | 2021-05-06 | — | — | WO | disclosed |
| CN-112218849-A | Process for preparing amines | 巴斯夫欧洲公司 | 2021-01-12 | — | — | CN | disclosed |
| CN-108586251-B | Preparation method of benzoyl para-difluoroalkylated derivative | 苏州大学 | 2021-01-12 | — | — | CN | disclosed |
| CN-112209841-A | Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate | 扬州中宝药业股份有限公司 | 2021-01-12 | — | — | CN | disclosed |
| CN-112209841-A | Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate | 扬州中宝药业股份有限公司 | 2021-01-12 | — | — | CN | disclosed |
| US-10881700-B1 | Compositions including extracts of gray mangrove leaves and methods of treatment using such compositions in treatment of viral infections | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2021-01-05 | — | — | US | disclosed |
| EP-3543227-B1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD (CN) | 2020-12-30 | — | — | EP | disclosed |
| EP-3543227-B1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD (CN) | 2020-12-30 | — | — | EP | disclosed |
| WO-2020204733-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2020-10-08 | — | — | WO | disclosed |
| US-20200308023-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2020-10-01 | — | — | US | disclosed |
| EP-3691996-A2 | A SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | Aquafortus Technologies Limited (NZ) | 2020-08-12 | — | — | EP | disclosed |
| CN-108124448-B | Amines for low emission epoxy resin compositions | SIKA技术股份公司 | 2020-08-11 | — | — | CN | disclosed |
| US-20200239496-A1 | Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents | Ludwig-Maximilians-Universitat München (DE) | 2020-07-30 | — | — | US | disclosed |
| WO-2020139001-A1 | PHARMACEUTICAL COMPOSITION FOR PROMOTION OF INTRACELLULAR ATP PRODUCTION | 고려대학교 산학협력단 | 2020-07-02 | — | — | WO | disclosed |
| CN-108276376-B | Novel diphenylpropenes derivative, preparation method thereof and pharmaceutical composition | 北京理工大学 | 2020-06-05 | — | — | CN | disclosed |
| CN-111225875-A | Salt recovery solution and method of using salt recovery solution | 阿克福特斯技术有限公司 | 2020-06-02 | — | — | CN | disclosed |
| US-20200062716-A1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) | 2020-02-27 | — | — | US | disclosed |
| US-20200062716-A1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) | 2020-02-27 | — | — | US | disclosed |
| WO-2019008537-A9 | MEDICAL COMPOUNDS | VERA SALUS RICERCA S.R.L. (IT) | 2020-02-20 | — | — | WO | disclosed |
| WO-2019214681-A1 | HETEROARYL COMPOUNDS AND USES THEREOF | APRINOIA THERAPEUTICS INC. (CN) | 2019-11-14 | — | — | WO | disclosed |
| EP-3344677-B1 | LOW-EMISSION EPOXY RESIN COMPOSITION | SIKA TECH AG (CH) | 2019-11-06 | — | — | EP | disclosed |
| US-10441586-B2 | CRMP2 SUMOylation inhibitors and uses thereof | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2019-10-15 | — | — | US | disclosed |
| EP-3543227-A1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | Guangdong Zhongsheng Pharmaceutical Co., Ltd (CN) | 2019-09-25 | — | — | EP | disclosed |
| EP-3543227-A1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | Guangdong Zhongsheng Pharmaceutical Co., Ltd (CN) | 2019-09-25 | — | — | EP | disclosed |
| CN-106715515-B | Amines for low emission epoxy resin compositions | SIKA技术股份公司 | 2019-08-16 | — | — | CN | disclosed |
| EP-3350245-B1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECH AG (CH) | 2019-08-14 | — | — | EP | disclosed |
| CN-109952290-A | FGFR4 inhibitor and its preparation method and application | 广东众生药业股份有限公司 | 2019-06-28 | — | — | CN | disclosed |
| US-10301423-B2 | Amine for low-emission epoxy resin compositions | SIKA TECHNOLOGY AG (CH) | 2019-05-28 | — | — | US | disclosed |
| US-20190112275-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2019-04-18 | — | — | US | disclosed |
| US-20190112275-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2019-04-18 | — | — | US | disclosed |
| WO-2019063418-A1 | HYDROCARBON-SOLUBLE HALOGEN AND THIOLATE/MAGNESIUM EXCHANGE REAGENTS | ALBEMARLE GERMANY GMBH (DE) | 2019-04-04 | — | — | WO | disclosed |
| US-20190048127-A1 | LOW-EMISSION EPOXY RESIN COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2019-02-14 | — | — | US | disclosed |
| WO-2019008537-A1 | MEDICAL COMPOUNDS | VERA SALUS RICERCA S.R.L. (IT) | 2019-01-10 | — | — | WO | disclosed |
| CN-109157435-A | A kind of sterilization, the bacteriostatic hand sanitizer of Chinese prickly ash and Mongollian Thyme Herb essential oil | 陕西为康食品科技股份有限公司 | 2019-01-08 | — | — | CN | disclosed |
| US-20190002628-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2019-01-03 | — | — | US | disclosed |
| EP-3180383-B1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECH AG (CH) | 2018-10-10 | — | — | EP | disclosed |
| CN-108586251-A | A kind of preparation method of benzoyl contraposition fluoroalkyl derivative | 苏州大学 | 2018-09-28 | — | — | CN | disclosed |
| WO-2018144900-A1 | SMALL MOLECULE ANTAGONISTS OF SUMO RELATED MODIFICATION OF CRMP2 AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2018-08-09 | — | — | WO | disclosed |
| EP-3350245-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2018-07-25 | — | — | EP | disclosed |
| CN-108276376-A | Novel two allyl benzene derivatives of one kind and preparation method thereof, a kind of pharmaceutical composition | 北京理工大学 | 2018-07-13 | — | — | CN | disclosed |
| EP-3344677-A1 | LOW-EMISSION EPOXY RESIN COMPOSITION | Sika Technology AG (CH) | 2018-07-11 | — | — | EP | disclosed |
| WO-2018111904-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC (US) | 2018-06-21 | — | — | WO | disclosed |
| US-20180162822-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2018-06-14 | — | — | US | disclosed |
| US-20180162822-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2018-06-14 | — | — | US | disclosed |
| CN-108124448-A | For the amine of low emission composition epoxy resin | SIKA技术股份公司 | 2018-06-05 | — | — | CN | disclosed |
| US-9983475-B2 | Fluorinated sulfonate esters of aryl ketones for non-ionic photo-acid generators | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-05-29 | — | — | US | disclosed |
| CN-107922585-A | Low Emission Epoxy Resin Composition | SIKA技术股份公司 | 2018-04-17 | — | — | CN | disclosed |
| US-20180046077-A1 | FLUORINATED SULFONATE ESTERS OF ARYL KETONES FOR NON-IONIC PHOTO-ACID GENERATORS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-02-15 | — | — | US | disclosed |
| US-20180044284-A1 | NON-IONIC LOW DIFFUSING PHOTO-ACID GENERATORS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-02-15 | — | — | US | disclosed |
| US-9856254-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-01-02 | — | — | US | disclosed |
| US-9856236-B2 | Substituted quinoxalines as FGFR kinase inhibitors | ASTEX THERAPEUTICS LTD (GB) | 2018-01-02 | — | — | US | disclosed |
| EP-3107900-B1 | 5-BENZYLISOQUINOLEINE DERIVATIVES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | SERVIER LAB (FR) | 2017-11-15 | — | — | EP | disclosed |
| US-9809553-B2 | Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2017-11-07 | — | — | US | disclosed |
| US-9809553-B2 | Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2017-11-07 | — | — | US | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-9776988-B2 | Pyrazolylbenzo[d]imidazole derivatives | CELON PHARMA S.A. (PL) | 2017-10-03 | — | — | US | disclosed |
| US-20170218114-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2017-08-03 | — | — | US | disclosed |
| WO-2017125634-A1 | TRPM8 RECEPTOR AGONIST COMPOUNDS AND USES THEREOF | UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE (ES) | 2017-07-27 | — | — | WO | disclosed |
| EP-1921077-B1 | AGENT FOR TREATING AND/OR PREVENTING SLEEP DISORDER | KYOWA HAKKO KIRIN CO LTD (JP) | 2017-07-26 | — | — | EP | disclosed |
| EP-3180383-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2017-06-21 | — | — | EP | disclosed |
| US-9682954-B2 | Phenanthridine derivatives, preparation methods and uses thereof | KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) | 2017-06-20 | — | — | US | disclosed |
| CN-106715515-A | Amines for low emission epoxy resin compositions | SIKA技术股份公司 | 2017-05-24 | — | — | CN | disclosed |
| US-20170137385-A1 | ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2017-05-18 | — | — | US | disclosed |
| US-20170137385-A1 | ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LES LABORATOIRES SERVIER (FR) | 2017-05-18 | — | — | US | disclosed |
| US-9604933-B2 | Pyrazolochalcones as potential anticancer agents | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-03-28 | — | — | US | disclosed |
| WO-2017046292-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2017-03-23 | — | — | WO | disclosed |
| EP-3144335-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2017-03-22 | — | — | EP | disclosed |
| WO-2017037069-A1 | LOW-EMISSION EPOXY RESIN COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2017-03-09 | — | — | WO | disclosed |
| EP-3138863-A1 | LOW-EMISSION EPOXY RESIN COMPOSITION | Sika Technology AG (CH) | 2017-03-08 | — | — | EP | disclosed |
| CN-104974135-B | Targeting DNA has the Sai-Mi-Xi-Bu derivative containing benzene-naphthalene diimide structure of antitumor activity, pharmaceutical composition and its preparation method and application | 河北大学 | 2017-03-08 | — | — | CN | disclosed |
| US-9586925-B2 | 1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia | NOBEL ILAÇ SANAYII VE TICARET A.S. (TR) | 2017-03-07 | — | — | US | disclosed |
| EP-3121176-A1 | 2,4-DIAMINOQUINAZOLINES FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY | Families of Spinal Muscular Atrophy (US) | 2017-01-25 | — | — | EP | disclosed |
| US-9518076-B2 | Apparatus and process for preparing reactive lignin with high yield from plant biomass for production of fuels and chemicals | WASHINGTON STATE UNIVERSITY (US) | 2016-12-13 | — | — | US | disclosed |
| US-20160280707-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES CO (US) | 2016-09-29 | — | — | US | disclosed |
| US-20160280707-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES CO (US) | 2016-09-29 | — | — | US | disclosed |
| EP-2922834-B1 | 1-(DIMETHYLAMINO)ETHYL-SUBSTITUTED 6H-BENZO[C]CHROMEN-6-ONES AGAINST SENILE DEMENTIA | NOBEL ILAÇ SANAYII VE TICARET A S (TR) | 2016-08-24 | — | — | EP | disclosed |
| EP-1765810-B1 | 2,4-DIAMINOQUINAZOLINES FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY | FAMILIES OF SPINAL MUSCULAR ATROPHY (US) | 2016-08-17 | — | — | EP | disclosed |
| EP-2514748-B1 | 2,4-diaminoquinazolines for spinal muscular atrophy | FAMILIES OF SPINAL MUSCULAR ATROPHY (US) | 2016-08-10 | — | — | EP | disclosed |
| CN-105795004-A | Oil composition capable of improving flavor and preparation method thereof | 丰益(上海)生物技术研发中心有限公司 | 2016-07-27 | — | — | CN | disclosed |
| US-20160207888-A1 | PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-07-21 | — | — | US | disclosed |
| US-9382282-B2 | Metal catalyzed oxidation of lignin and related compounds | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160177184-A1 | Bio-Oils and Methods of Producing Bio-Oils from Guayule Bagasse and/or Leaves | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2016-06-23 | — | — | US | disclosed |
| US-9365567-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-06-14 | — | — | US | disclosed |
| US-9365567-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-06-14 | — | — | US | disclosed |
| US-20160152577-A1 | 2,4-Diaminoquinazolines for Spinal Muscular Atrophy | FAMILIES OF SPINAL MUSCULAR ATROPHY (US) | 2016-06-02 | — | — | US | disclosed |
| US-20160107967-A1 | METHOD FOR THE DEPOLYMERIZATION OF LIGNIN | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2016-04-21 | — | — | US | disclosed |
| US-20160083364-A1 | Phenanthridine Derivatives, Preparation Methods and Uses Thereof | CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) | 2016-03-24 | — | — | US | disclosed |
| US-9290478-B2 | Substituted quinoxalines as FGFR kinase inhibitors | ASTEX THERAPEUTICS LTD (GB) | 2016-03-22 | — | — | US | disclosed |
| US-20160060254-A1 | THIAZOLE-BASED INHIBITORS OF SCAVENGER RECEPTOR BI | THE BROAD INSTITUTE, INC. | 2016-03-03 | — | — | US | disclosed |
| WO-2016023839-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2016-02-18 | — | — | WO | disclosed |
| EP-2984065-A1 | METHOD FOR THE DEPOLYMERIZATION OF LIGNIN | Stichting Dienst Landbouwkundig Onderzoek (NL) | 2016-02-17 | — | — | EP | disclosed |
| US-20160039794-A1 | PYRAZOLYLBENZO[D]IMIDAZOLE DERIVATIVES | CELON PHARMA S.A. (PL) | 2016-02-11 | — | — | US | disclosed |
| US-20160031856-A1 | SUBSTITUTED QUINOXALINES AS FGFR KINASE INHIBITORS | ASTEX THERAPEUTICS LTD (GB) | 2016-02-04 | — | — | US | disclosed |
| US-20160002194-A1 | 1 -(DIMETHYLAMINO)ETHYL-SUBSTITUTED 6H-BENZO[C]CHROMEN-6-ONES AGAINST SENILE DEMENTIA | NOBEL ILAÇ SANAYII VE TICARET A.S (TR) | 2016-01-07 | — | — | US | disclosed |
| CN-104974135-A | Targeted DNA (deoxyribonucleic acid) naphthyldiimide-structure-containing celecoxib derivatives with antitumor activity, pharmaceutical composition, and preparation method and application thereof | UNIV HEBEI | 2015-10-14 | — | — | CN | disclosed |
| EP-2922834-A1 | 1 -(DIMETHYLAMINO)ETHYL-SUBSTITUTED 6H-BENZO[C]CHROMEN-6-ONES AGAINST SENILE DEMENTIA | Nobel Ilaç Sanayii Ve Ticaret A.S. (TR) | 2015-09-30 | — | — | EP | disclosed |
| US-9145394-B2 | — | — | 2015-09-29 | — | — | US | disclosed |
| US-9139694-B1 | High temperature materials with low moisture uptake made from lichen metabolites | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-09-22 | — | — | US | disclosed |
| WO-2015124877-A1 | DERIVATIVES OF 5-BENZYLISOQUINOLINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | LES LABORATOIRES SERVIER (FR) | 2015-08-27 | — | — | WO | disclosed |
| EP-2900645-A1 | 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION | Bayer CropScience AG (DE) | 2015-08-05 | — | — | EP | disclosed |
| US-9067897-B2 | 2,4-Diaminoquinazolines for spinal muscular atrophy | FAMILIES OF SPINAL MUSCULAR ATROPHY (US) | 2015-06-30 | — | — | US | disclosed |
| EP-1673087-B1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES CO (US) | 2015-05-13 | — | — | EP | disclosed |
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | WASHINGTON STATE UNIVERSITY (US) | 2015-04-09 | — | — | US | disclosed |
| EP-2646432-B1 | SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES | ASTEX THERAPEUTICS LTD (GB) | 2015-04-08 | — | — | EP | disclosed |
| CN-104496770-A | Method for producing acetophenone compound employing arylethynylene hydration reaction | UNIV HUNAN | 2015-04-08 | — | — | CN | disclosed |
| WO-2015029051-A1 | PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-03-05 | — | — | WO | disclosed |
| WO-2015021079-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2015-02-12 | — | — | WO | disclosed |
| WO-2015016729-A1 | UREA COMPOUNDS AND THEIR USE AS FAAH ENZYME INHIBITORS | BIAL - PORTELA & Cª, S.A. (PT) | 2015-02-05 | — | — | WO | disclosed |
| WO-2015016729-A1 | UREA COMPOUNDS AND THEIR USE AS FAAH ENZYME INHIBITORS | BIAL - PORTELA & Cª, S.A. (PT) | 2015-02-05 | — | — | WO | disclosed |
| US-20150023990-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES COMPANY | 2015-01-22 | — | — | US | disclosed |
| US-20150023990-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | 3M INNOVATIVE PROPERTIES COMPANY | 2015-01-22 | — | — | US | disclosed |
| US-8889718-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| US-8871782-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-10-28 | — | — | US | disclosed |
| WO-2014168473-A1 | METHOD FOR THE DEPOLYMERIZATION OF LIGNIN | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2014-10-16 | — | — | WO | disclosed |
| WO-2014131368-A1 | PHENANTHRIDINE DERIVATIVES, PREPARATION METHODS THEREFOR AND USES THEREOF | 中国科学院昆明植物研究所 (CN) | 2014-09-04 | — | — | WO | disclosed |
| US-20140249300-A1 | Metal Catalyzed Oxidation of Lignin and Related Compounds | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2014-09-04 | — | — | US | disclosed |
| WO-2014129990-A1 | 1 -(DIMETHYLAMINO)ETHYL-SUBSTITUTED 6H-BENZO[C]CHROMEN-6-ONES AGAINST SENILE DEMENTIA | FARGEM FARMASÖTİK ARAŞTIRMA GELİŞTİRME MERKEZİ SANAYİİ VE TİCARET A.Ş. (TR) | 2014-08-28 | — | — | WO | disclosed |
| CN-103370314-A | Substituted benzopyrazin derivatives as FGFR kinase inhibitors for the treatment of cancer diseases | ASTEX THERAPEUTICS LTD | 2013-10-23 | — | — | CN | disclosed |
| US-20130267509-A1 | THIAZOLE DERIVATIVES | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2013-10-10 | — | — | US | disclosed |
| US-20130267525-A1 | SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES | ASTEX THERAPEUTICS LIMITED (GB) | 2013-10-10 | — | — | US | disclosed |
| EP-2646432-A1 | SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES | Astex Therapeutics Limited (GB) | 2013-10-09 | — | — | EP | disclosed |
| US-20130203709-A1 | ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME | THE PENN STATE RESEARCH FOUNDATION (US) | 2013-08-08 | — | — | US | disclosed |
| EP-2401256-B1 | Compounds as bradykinin B1 antagonists | BOEHRINGER INGELHEIM INT (DE) | 2013-04-17 | — | — | EP | disclosed |
| US-8420827-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8420827-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2013-04-16 | — | — | US | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| WO-2013036911-A1 | METAL CATALYZED OXIDATION OF LIGNIN AND RELATED COMPOUNDS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-03-14 | — | — | WO | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| CN-101665418-B | Methods for preparing E-3,5-dimethoxy-4'-oxhydryl diphenylethene and derivative thereof | GUANGZHOU INST OF CHEMISTRY | 2012-11-28 | — | — | CN | disclosed |
| US-8313814-B2 | Cellulose acylate film, method of producing the same, cellulose derivative film, optically compensatory film using the same, optically-compensatory film incorporating polarizing plate, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| US-8313814-B2 | Cellulose acylate film, method of producing the same, cellulose derivative film, optically compensatory film using the same, optically-compensatory film incorporating polarizing plate, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-11-20 | — | — | US | disclosed |
| US-8299055-B2 | 8-substituted isoquinoline derivative and the use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2012-10-30 | — | — | US | disclosed |
| EP-2514748-A1 | 2,4-diaminoquinazolines for spinal muscular atrophy | Families of Spinal Muscular Atrophy (US) | 2012-10-24 | — | — | EP | disclosed |
| CN-101665419-B | Method for preparing (Z)-3'-hydroxy-3,4',5-trimethoxy diphenylethene | GUANGZHOU INST OF CHEMISTRY | 2012-10-03 | — | — | CN | disclosed |
| US-8221855-B2 | Cellulose derivative film, optical compensation film, polarizing plate, and liquid crystal device | FUJIFILM CORPORATION (JP) | 2012-07-17 | — | — | US | disclosed |
| US-8221855-B2 | Cellulose derivative film, optical compensation film, polarizing plate, and liquid crystal device | FUJIFILM CORPORATION (JP) | 2012-07-17 | — | — | US | disclosed |
| EP-2462120-A1 | FUNGICIDAL DIPHENYL-SUBSTITUTED PYRIDAZINES | E. I. du Pont de Nemours and Company (US) | 2012-06-13 | — | — | EP | disclosed |
| WO-2012073017-A1 | SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES | ASTEX THERAPEUTICS LIMITED (GB) | 2012-06-07 | — | — | WO | disclosed |
| US-20120135995-A1 | FUNGICIDAL DIPHENYL-SUBSTITUTED PYRIDAZINES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2012-05-31 | — | — | US | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-8143270-B2 | 2-amino 1H-in-imidazo ring systems and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143270-B2 | 2-amino 1H-in-imidazo ring systems and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| CN-102321014-A | Novel di-phenylpyridine derivative | SHENYANG ELIVING PHARM TECHNOLOGY CO LTD | 2012-01-18 | — | — | CN | disclosed |
| EP-1899763-B1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORP (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-8043714-B2 | Transparent thermoplastic film and a method of producing the same | FUJIFILM CORPORATION (JP) | 2011-10-25 | — | — | US | disclosed |
| US-7993562-B2 | Method of producing a thermoplastic film | FUJIFILM CORPORATION (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7981488-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7981488-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7976914-B2 | Resin film, production method thereof, polarizing plate and liquid crystal display device | FUJIFILM CORPORATON (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7976914-B2 | Resin film, production method thereof, polarizing plate and liquid crystal display device | FUJIFILM CORPORATON (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20110160228-A1 | DIHYDRO-ISO-CA-4 AND ANALOGUES: POTENT CYTOTOXICS, INHIBITORS OF TUBULIN POLYMERIZATION | CENTRE NATIONAL DE LA RECHERCHE SCIENRIFIQUE (CNRS) | 2011-06-30 | — | — | US | disclosed |
| US-20110112118-A1 | 2,4-Diaminoquinazolines for Spinal Muscular Atrophy | FAMILIES OF SPINAL MUSCULAR ATROPHY (US) | 2011-05-12 | — | — | US | disclosed |
| US-7928098-B2 | Therapeutic and/or preventive agents for a sleep disorder | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-7928098-B2 | Therapeutic and/or preventive agents for a sleep disorder | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| WO-2011033022-A2 | OSMIUM COMPLEXES USABLE AS CATALYSTS FOR THE REDUCTION OF CARBONYL COMPOUNDS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2011-03-24 | — | — | WO | disclosed |
| EP-2297075-A1 | DIHYDRO-ISO-CA-4 AND ANALOGUES: POTENT CYTOTOXICS, INHIBITORS OF TUBULIN POLYMERIZATION | Centre National de la Recherche Scientifique (C.N.R.S) (FR) | 2011-03-23 | — | — | EP | disclosed |
| EP-1432669-B1 | 4-(C2-6 ALKOXY)-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | SPEAR THERAPEUTICS LTD (GB) | 2011-03-23 | — | — | EP | disclosed |
| US-7888366-B2 | 2,4-diaminoquinazolines for spinal muscular atrophy | FAMILIES OF SPINAL MUSCULAR ATROPHY (US) | 2011-02-15 | — | — | US | disclosed |
| US-7888349-B2 | Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-02-15 | — | — | US | disclosed |
| US-7888349-B2 | Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-02-15 | — | — | US | disclosed |
| WO-2011017261-A1 | FUNGICIDAL DIPHENYL-SUBSTITUTED PYRIDAZINES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-10 | — | — | WO | disclosed |
| US-7880013-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-7880013-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| EP-1633733-B1 | CANNABINOID DERIVATIVES, METHODS OF MAKING, AND USE THEREOF | UNIV TENNESSEE RES FOUNDATION (US) | 2011-01-26 | — | — | EP | disclosed |
| US-20100261701-A1 | 8-Substituted isoquinoline derivative and the use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
| US-20100256361-A1 | THIAZOLE DERIVATIVES | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-10-07 | — | — | US | disclosed |
| US-20100256361-A1 | THIAZOLE DERIVATIVES | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-10-07 | — | — | US | disclosed |
| US-20100189795-A1 | CALCIUM SEQUESTRATION COMPOSITIONS AND METHODS OF TREATING SKIN PIGMENTATION DISORDERS AND CONDITIONS | NEOCUTIS S.A. (CH) | 2010-07-29 | — | — | US | disclosed |
| US-20100152162-A1 | THERAPEUTIC AND/OR PREVENTIVE AGENTS FOR A SLEEP DISORDER | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100152162-A1 | THERAPEUTIC AND/OR PREVENTIVE AGENTS FOR A SLEEP DISORDER | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-7718808-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-05-18 | — | — | US | disclosed |
| US-7718808-B2 | Thiazole derivatives | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-05-18 | — | — | US | disclosed |
| US-20100090364-A1 | METHOD OF PRODUCING TRANSPARENT THERMOPLASTIC FILM AND TRANSPARENT THERMOPLASTIC FILM | FUJIFILM CORPORATION (JP) | 2010-04-15 | — | — | US | disclosed |
| WO-2010038465-A1 | 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF | 旭化成ファーマ株式会社 (JP) | 2010-04-08 | — | — | WO | disclosed |
| CN-101665418-A | Methods for preparing E-3,5-dimethoxy-4'-oxhydryl diphenylethene and derivative thereof | GUANGZHOU INST OF CHEMISTRY | 2010-03-10 | — | — | CN | disclosed |
| CN-101665419-A | Method for preparing (Z)-3'-hydroxy-3,4',5-trimethoxy diphenylethene | GUANGZHOU INST OF CHEMISTRY | 2010-03-10 | — | — | CN | disclosed |
| US-7667801-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-02-23 | — | — | US | disclosed |
| US-7667801-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-02-23 | — | — | US | disclosed |
| US-20100028262-A1 | 3,4-METHYLENEDIOXY-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | SPEAR THERAPEUTICS LIMITED (GB) | 2010-02-04 | — | — | US | disclosed |
| US-7646457-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-7646457-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-20090325962-A1 | TYROSINE DERIVATIVE | GENENTECH, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| WO-2009147217-A1 | DIHYDRO-ISO-CA-4 AND ANALOGUES: POTENT CYTOTOXICS, INHIBITORS OF TUBULIN POLYMERIZATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2009-12-10 | — | — | WO | disclosed |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | disclosed |
| US-20090290100-A1 | Cellulose Acylate Film, Method of Producing the Same, Cellulose Derivative Film, Optically Compensatory Film Using the Same, Optically-Compensatory Film Incorporating Polarizing Plate, Polarizing Plate and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-11-26 | — | — | US | disclosed |
| US-20090290100-A1 | Cellulose Acylate Film, Method of Producing the Same, Cellulose Derivative Film, Optically Compensatory Film Using the Same, Optically-Compensatory Film Incorporating Polarizing Plate, Polarizing Plate and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-11-26 | — | — | US | disclosed |
| US-20090251650-A1 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090251650-A1 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2009-10-08 | — | — | US | disclosed |
| US-7598294-B2 | Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy | SPEAR THERAPEUTICS LIMITED (GB) | 2009-10-06 | — | — | US | disclosed |
| US-7595399-B2 | Tyrosine derivatives | GENENTECH, INC. (US) | 2009-09-29 | — | — | US | disclosed |
| US-20090153782-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090153782-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-06-18 | — | — | US | disclosed |
| US-7538141-B2 | Compounds for the treatment of diseases | PFIZER INC. | 2009-05-26 | — | — | US | disclosed |
| US-20090117294-A1 | CELLULOSE DERIVATIVE FILM, OPTICAL COMPENSATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DEVICE | FUJIFILM CORPORATION (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20090117294-A1 | CELLULOSE DERIVATIVE FILM, OPTICAL COMPENSATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DEVICE | FUJIFILM CORPORATION (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20090109379-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM COPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090109379-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM COPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| US-7511145-B2 | Bicyclic heteroaryl derivatives | GENELABS TECHNOLOGIES, INC. (US) | 2009-03-31 | — | — | US | disclosed |
| US-20090081165-A1 | BICYCLIC HETEROARYL DERIVATIVES | GENELABS TECHNOLOGIES, INC. | 2009-03-26 | — | — | US | disclosed |
| US-20090021673-A1 | Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090021673-A1 | Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090023720-A1 | 2-Amino 1H-Imidazo Ring Systems and Methods | 3M INNOVATIVE PROPERTIES COMPANY | 2009-01-22 | — | — | US | disclosed |
| US-20090023720-A1 | 2-Amino 1H-Imidazo Ring Systems and Methods | 3M INNOVATIVE PROPERTIES COMPANY | 2009-01-22 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-20080113994-A1 | Annelated Quinoline Derivatives As Pesticide | VELTEN ROBERT | 2008-05-15 | — | — | US | disclosed |
| US-20080113994-A1 | Annelated Quinoline Derivatives As Pesticide | VELTEN ROBERT | 2008-05-15 | — | — | US | disclosed |
| US-20080113994-A1 | Annelated Quinoline Derivatives As Pesticide | VELTEN ROBERT | 2008-05-15 | — | — | US | disclosed |
| US-20080075719-A1 | Method for Augmenting B Cell Depletion | GENENTECH, INC. (US) | 2008-03-27 | — | — | US | disclosed |
| US-20080004290-A1 | Anti-Cancer Agents | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-01-03 | — | — | US | disclosed |
| US-20080004290-A1 | Anti-Cancer Agents | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-01-03 | — | — | US | disclosed |
| US-20070290168-A1 | Resin film, production method thereof, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070290168-A1 | Resin film, production method thereof, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| US-20070286998-A1 | Method of producing transparent thermoplastic film and transparent thermoplastic film | FUJIFILM CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
| US-20070281112-A1 | Thermoplastic film and method of producing the same, polarizing plate, optical compensation film, antireflection film and liquid-crystal display device | FUJIFILM CORPORATION (JP) | 2007-12-06 | — | — | US | disclosed |
| US-20070275183-A1 | Transparent thermoplastic film and a method of producing the same | FUJIFILM CORPORATION (JP) | 2007-11-29 | — | — | US | disclosed |
| EP-1856075-A1 | SUBSTITUTED ARYLAMINE COMPOUNDS AND THEIR USE AS 5-HT6 MODULATORS | Epix Delaware, Inc. (US) | 2007-11-21 | — | — | EP | disclosed |
| US-20070259134-A1 | Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| US-20070259134-A1 | Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| EP-1844042-A1 | INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | GENELABS TECHNOLOGIES, INC. (US) | 2007-10-17 | — | — | EP | disclosed |
| WO-2007111388-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-10-04 | — | — | WO | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| WO-2007086599-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | WO | disclosed |
| US-20070167514-A1 | Cannabinoid derivatives, methods of making, and use thereof | UNIVERSTIY OF TENNESSEE RESEARCH FOUNDATION | 2007-07-19 | — | — | US | disclosed |
| US-20070167476-A1 | Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-19 | — | — | US | disclosed |
| US-20070167476-A1 | Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-19 | — | — | US | disclosed |
| WO-2007037539-A9 | CELLULOSE DERIVATIVE FILM, OPTICAL COMPENSATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DEVICE | FUJIFILM CORP (JP) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007061139-A1 | CELLULOSE ACYLATE FILM, METHOD OF PRODUCING THE SAME, CELLULOSE DERIVATIVE FILM, OPTICALLY COMPENSATORY FILM USING THE SAME, OPTICALLY-COMPENSATORY FILM INCORPORATING POLARIZING PLATE, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-05-31 | — | — | WO | disclosed |
| US-20070105919-A1 | adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070105919-A1 | adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| WO-2007037539-A1 | CELLULOSE DERIVATIVE FILM, OPTICAL COMPENSATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DEVICE | FUJIFILM CORPORATION (JP) | 2007-04-05 | — | — | WO | disclosed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | disclosed |
| EP-1765810-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | Decode Chemistry, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-03-15 | — | — | US | disclosed |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-03-15 | — | — | US | disclosed |
| WO-2007023990-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJI FILM CORPORATION (JP) | 2007-03-01 | — | — | WO | disclosed |
| US-7169942-B2 | agonists or antagonists; treatment for neuroinflammatory pathologies involving demyelinization, viral encephalitis, cerebrovascular accidents, cranial trauma, ocular disorders, pulmonary disorders, allergic diseases, inflammatory conditions, immune system disorders, central nervous system diseases, etc. | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-01-30 | — | — | US | disclosed |
| EP-1735317-A1 | ANNELATED QUINOLINE DERIVATIVES AS PESTICIDE | Bayer CropScience Aktiengesellschaft (DE) | 2006-12-27 | — | — | EP | disclosed |
| CN-1843234-A | Additive for intensifying flavor of England type fire cured tobacco taste | YUNNAN TOBACCO SCI RES INST (CN) | 2006-10-11 | — | — | CN | disclosed |
| US-7112698-B2 | 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents | SPEAR THERAPEUTICS LIMITED (GB) | 2006-09-26 | — | — | US | disclosed |
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | GENELABS, INC. | 2006-09-21 | — | — | US | disclosed |
| US-20060205737-A1 | Substituted arylamine compounds and methods of treatment | GALENEA CORPORATION | 2006-09-14 | — | — | US | disclosed |
| US-7105670-B2 | Intermediates useful in the preparation of diaminothiazoles | HOFFMANN-LA ROCHE INC. (US) | 2006-09-12 | — | — | US | disclosed |
| US-7094896-B2 | Diaminothiazoles having antiproliferative activity | HOFFMANN-LA ROCHE INC. (US) | 2006-08-22 | — | — | US | disclosed |
| WO-2006081332-A1 | SUBSTITUTED ARYLAMINE COMPOUNDS AND THEIR USE AS 5-HT6 MODULATORS | EPIX DELAWARE, INC. (US) | 2006-08-03 | — | — | WO | disclosed |
| WO-2006076529-A1 | INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | GENELABS TECHNOLOGIES, INC. (US) | 2006-07-20 | — | — | WO | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-7074820-B2 | Amidino derivatives and their use as thrombin inhibitors | ASTRAZENECA AB (SE) | 2006-07-11 | — | — | US | disclosed |
| EP-1284952-B1 | SUBSTITUTED CHALCONES AS THERAPEUTIC COMPOUNDS | CANCER REC TECH LTD (GB) | 2006-06-21 | — | — | EP | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1358169-B1 | DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE | HOFFMANN LA ROCHE (CH) | 2006-01-11 | — | — | EP | disclosed |
| WO-2005123724-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | DECODE CHEMISTRY, INC. (US) | 2005-12-29 | — | — | WO | disclosed |
| US-20050288314-A1 | 2,4-diaminoquinazolines for spinal muscular atrophy | DECODE CHEMISTRY, INC. (US) | 2005-12-29 | — | — | US | disclosed |
| WO-2005097802-A1 | ANNELATED QUINOLINE DERIVATIVES AS PESTICIDE | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2005-10-20 | — | — | WO | disclosed |
| US-20050187390-A1 | Bicyclic heteroaryl derivatives | GENELABS TECHNOLOGIES, INC. | 2005-08-25 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| US-20050113283-A1 | Methods of treating conditions associated with an EDG-4 receptor | MANIV ENERGY CAPITAL | 2005-05-26 | — | — | US | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| EP-1513522-A2 | METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG RECEPTOR | SRI INTERNATIONAL (US) | 2005-03-16 | — | — | EP | disclosed |
| US-6867218-B2 | Compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2005-03-15 | — | — | US | disclosed |
| US-20040259957-A1 | 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents | SPEAR THERAPEUTICS LIMITED (GB) | 2004-12-23 | — | — | US | disclosed |
| US-20040254149-A1 | 3, 4-Methylenedioxy-substituted chalcones as therapeutic agents | SPEAR THERAPEUTICS LIMITED (GB) | 2004-12-16 | — | — | US | disclosed |
| US-6787672-B2 | 1-(4-METHOXYPHENYL)-3-(3,5-DIMETHOXYPHENYL)PROP-1-EN-3-ONE DERIVATIVES; ANTIPROLIFERATIVE AND ANTIINFLAMMATORY AGENTS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2004-09-07 | — | — | US | disclosed |
| EP-1432413-A2 | 3,4-METHYLENEDIOXY-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | Cancer Research Technology Limited (GB) | 2004-06-30 | — | — | EP | disclosed |
| EP-1432669-A1 | 4-(C2-6 ALKOXY)-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | Cancer Research Technology Limited (GB) | 2004-06-30 | — | — | EP | disclosed |
| US-6756374-B2 | CYCLIN-DEPENDENT KINASE INHIBITORS SUCH AS (4-AMINO-2-((4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-5-THIAZOLYL) (2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)METHANONE FOR TREATMENT OF BREAST, LUNG, COLON, AND PROSTATE CANCER/TUMORS | HOFFMANN-LA ROCHE INC. | 2004-06-29 | — | — | US | disclosed |
| US-20040087594-A1 | Diaminothiazoles having antiproliferative activity | DING QINGJIE (US) | 2004-05-06 | — | — | US | disclosed |
| US-20040082595-A1 | Intermediates useful in the preparation of diaminothiazoles | DING QINGJIE (US) | 2004-04-29 | — | — | US | disclosed |
| EP-1358169-A2 | DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2003-11-05 | — | — | EP | disclosed |
| CN-1125046-C | Butadiene derivatives and process for producing the same | TANABE SEIYAKU CO (JP) | 2003-10-22 | — | — | CN | disclosed |
| US-20030195200-A1 | Compounds, their preparation and use | VTVX HOLDINGS II LLC | 2003-10-16 | — | — | US | disclosed |
| WO-2003062392-A2 | METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG RECEPTOR | CERETEK LLC (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20030100538-A1 | Anticancer and inflammatory agents; diagnosis | SPEAR THERAPEUTICS LIMITED (GB) | 2003-05-29 | — | — | US | disclosed |
| US-6555577-B1 | For treatment and/or prevention of conditions mediated by the Peroxisome Proliferator-Activated Receptors (PPAR), such as diabetes and/or obesity; 3-(4-(3-Biphenyl-4-yl-but-2-enyloxy)-phenyl)-2-butoxy-propionic acid for example | NOVO NORDISK A/S (DE) | 2003-04-29 | — | — | US | disclosed |
| WO-2003029176-A1 | 4-(C2-6ALKOXY)-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2003-04-10 | — | — | WO | disclosed |
| WO-2003028713-A2 | 3,4-METHYLENEDIOXY-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2003-04-10 | — | — | WO | disclosed |
| EP-1284952-A1 | SUBSTITUTED CHALCONES AS THERAPEUTIC COMPOUNDS | Cancer Research Technology Limited (GB) | 2003-02-26 | — | — | EP | disclosed |
| CN-1396903-A | novel compounds, their preparation and use | NOVO NORDISK AS (DK) | 2003-02-12 | — | — | CN | disclosed |
| US-20020151554-A1 | Diaminothiazoles having antiproliferative activity | CHEN LI (US) | 2002-10-17 | — | — | US | disclosed |
| EP-0917528-B1 | NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | ASTRAZENECA AB (SE) | 2002-09-18 | — | — | EP | disclosed |
| WO-2002057261-A2 | DIAMINOTHIAZOLES AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-25 | — | — | WO | disclosed |
| EP-0889879-B1 | BUTADIENE DERIVATIVES AND PROCESS FOR PREPARING THEREOF | TANABE SEIYAKU CO (JP) | 2002-06-12 | — | — | EP | disclosed |
| EP-0924202-B1 | Imidazole derivative and medicine comprising the same as active ingredient | SSP CO LTD (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-20020040043-A1 | Amidino derivatives and their use as thrombin inhibitors | ANTONSSON THOMAS (SE) | 2002-04-04 | — | — | US | disclosed |
| US-6358750-B1 | FOR COMBINATORIAL LIBRARIES; DRUG SCREENING | ARQULE, INC. | 2002-03-19 | — | — | US | disclosed |
| EP-0735142-B1 | Process for producing (R)-styrene oxides | SUMIKA FINE CHEMICALS CO LTD (JP) | 2001-10-24 | — | — | EP | disclosed |
| WO-2001072680-A1 | SUBSTITUTED CHALCONES AS THERAPEUTIC COMPOUNDS | CANCER RESEARCH VENTURES LIMITED (GB) | 2001-10-04 | — | — | WO | disclosed |
| EP-1125937-A2 | Spiro [Pyrrolidine-2,3'-oxindole] compounds and methods of use | ARQULE, INC. (US) | 2001-08-22 | — | — | EP | disclosed |
| US-6248743-B1 | ANTITHROMBOTIC AGENTS EFFECTIVE TO INHIBIT THE PRODUCTION OF TYPE 1 PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) | TANABE SEIYAKU CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6221898-B1 | ANTICOAGULANTS | ASTRA AKTIEBOLAG (SE) | 2001-04-24 | — | — | US | disclosed |
| EP-0783505-B1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | NOVARTIS AG (CH) | 2001-03-07 | — | — | EP | disclosed |
| US-6093851-A | N-(α-alkylbenzylidene)-α-phenylalkylamine, its use and process for producing the same and process for producing intermediate therefor | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2000-07-25 | — | — | US | disclosed |
| US-6071943-A | IMMUNOMODULATORS WHICH SUPPRESS SPECIFIC CYTOKINES, FOR AUTOIMMUNE DISEASES | SSP CO. LTD. (JP) | 2000-06-06 | — | — | US | disclosed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | disclosed |
| US-6017916-A | Nonpeptide endothelin antagonists I | WARNER-LAMBERT COMPANY (US) | 2000-01-25 | — | — | US | disclosed |
| CN-1046731-C | Pyrrolo [2,3-d ] pyrimidines and their use | NOVARTIS AG (CH) | 1999-11-24 | — | — | CN | disclosed |
| CN-1228765-A | New amidino derivatives and their use as thrombin inhibitors | ASTRA AB (SE) | 1999-09-15 | — | — | CN | disclosed |
| US-5952355-A | 1-ETHER-SUBSTITUTED PHENYL-3-INDOL-3-YL-2-PROPEN-1-ONE DERIVATIVES; ANTITUMOR AND -CARCINOGENIC AGENTS; IMMUNOSUPPRESSANTS; AUTOIMMUNE DISEASES; SIDE EFFECT REDUCTION | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | disclosed |
| EP-0735018-B1 | N-(alpha-alkylbenzylidene)-alpha-phenylalkylamine, its use and process for producing the same and process for producing intermediate therefor | SUMITOMO CHEMICAL CO (JP) | 1999-07-21 | — | — | EP | disclosed |
| EP-0924202-A1 | Imidazole derivative and medicine comprising the same as active ingredient | SSP Co., Ltd. (JP) | 1999-06-23 | — | — | EP | disclosed |
| EP-0917528-A1 | NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | Astra Aktiebolag (SE) | 1999-05-26 | — | — | EP | disclosed |
| CN-1214678-A | Butadiene derivatives and process for preparing thereof | TANABE SEIYAKU CO (JP) | 1999-04-21 | — | — | CN | disclosed |
| US-5869485-A | Pyrrolo 2,3-d!pyrimidines and their use | NOVARTIS FINANCE CORP. (US) | 1999-02-09 | — | — | US | disclosed |
| US-5861229-A | WITH NOVOLAK RESIN AND TRIS/HYDROXYPHENYL/METHANES; BALANCE OF SENSITIVITY, RESOLUTION AND HEAT RESISTANCE; FOR COATING SILICON WAFERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-01-19 | — | — | US | disclosed |
| EP-0889879-A1 | BUTADIENE DERIVATIVES AND PROCESS FOR PREPARING THEREOF | TANABE SEIYAKU CO., LTD. (JP) | 1999-01-13 | — | — | EP | disclosed |
| EP-0687253-B1 | 4-AMINOPYRIDINES, PROCESS FOR PREPARING THE SAME AND MEDICAMENTS CONTAINING THE SAME | BOEHRINGER MANNHEIM GMBH (DE) | 1998-12-16 | — | — | EP | disclosed |
| EP-0358871-B1 | Radiation-sensitive positive resist composition | SUMITOMO CHEMICAL CO (JP) | 1998-09-30 | — | — | EP | disclosed |
| US-5777105-A | Process for the preparation of imidazolyl macrolide immunosuppressants | MERCK & CO., INC. (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0848717-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOLYL MACROLIDE IMMUNOSUPPRESSANTS | Merck & Co., Inc. (US) | 1998-06-24 | — | — | EP | disclosed |
| US-5739401-A | N-(α-alkylbenzylidene)-α-phenylalkylamine, its use and process for producing the same and process for producing intermediate therefor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-04-14 | — | — | US | disclosed |
| US-5717116-A | TREATING A MIXTURE OF PHENYLHALOGENOMETHYLCARBINOLS WITH A LIPASE IN THE PRESENCE OF A CARBOXYLATE FOLLOWED BY CYCLIZATION WITH A BASE | SUMIKA FINE CHEMICALS COMPANY, LIMITED (JP) | 1998-02-10 | — | — | US | disclosed |
| WO-1998001422-A1 | NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | ASTRA AKTIEBOLAG (SE) | 1998-01-15 | — | — | WO | disclosed |
| US-5691373-A | TREATING SUBARACHNOID HEMORRHAGE | WARNER-LAMBERT COMPANY (US) | 1997-11-25 | — | — | US | disclosed |
| CN-1164234-A | Pyrrolo [2, 3-d ] pyrimidines and their use | NOVARTIS AG (CH) | 1997-11-05 | — | — | CN | disclosed |
| WO-1997036864-A1 | BUTADIENE DERIVATIVES AND PROCESS FOR PREPARING THEREOF | TANABE SEIYAKU CO., LTD. (JP) | 1997-10-09 | — | — | WO | disclosed |
| EP-0783505-A1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | Novartis AG (CH) | 1997-07-16 | — | — | EP | disclosed |
| EP-0770601-A1 | PROPENONE DERIVATIVES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1997-05-02 | — | — | EP | disclosed |
| WO-1997008182-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOLYL MACROLIDE IMMUNOSUPPRESSANTS | MERCK & CO., INC. (US) | 1997-03-06 | — | — | WO | disclosed |
| EP-0735142-A2 | Process for producing (R)-styrene oxides | SUMIKA FINE CHEMICAL COMPANY, LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
| EP-0735018-A1 | N-(alpha-alkylbenzylidene)-alpha-phenylalkylamine, its use and process for producing the same and process for producing intermediate therefor | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-10-02 | — | — | EP | disclosed |
| EP-0714391-A1 | SUBSTITUTED 2(5H)FURANONE, 2(5H)THIOPHENONE AND 2(5H)PYRROLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1996-06-05 | — | — | EP | disclosed |
| WO-1996010028-A1 | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE | NOVARTIS AG (CH) | 1996-04-04 | — | — | WO | disclosed |
| US-5498419-A | SIDE EFFECT REDUCTION | PARS HARRY G (US) | 1996-03-12 | — | — | US | disclosed |
| EP-0687253-A1 | NEW 4-AMINOPYRIDINES, PROCESS FOR PREPARING THE SAME AND MEDICAMENTS CONTAINING THE SAME | Roche Diagnostics GmbH (DE) | 1995-12-20 | — | — | EP | disclosed |
| WO-1995033429-A1 | FUMARATE SALT OF 4-(DIETHYL-3-(1-METHYLOCTYL)- 7, 8, 9, 10-TETRAHYDRO-6, 6, 9-TRIMETHYL-6H-DIBENZO[B, D]PYRAN-1-OL, 4-(DIETHYL-AMINO)BUTYRIC ACID ESTER | PARS HARRY G (US) | 1995-12-14 | — | — | WO | disclosed |
| US-5456995-A | With polyphenol compound to control dissolution rate | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-10-10 | — | — | US | disclosed |
| US-5456996-A | Containing photosensitive 1,2-quinone diazide compound, alkali soluble resin binder, polyphenol compound to control dissolution rate in developer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-10-10 | — | — | US | disclosed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |
| JP-H07206642-A | HAIR GROWTH AGENT AND COSMETIC FOR HAIR OF HEAD CONTAINING THE SAME | POLA CHEM IND INC | 1995-08-08 | — | — | JP | disclosed |
| WO-1995005376-A1 | SUBSTITUTED 2(5H)FURANONE, 2(5H)THIOPHENONE AND 2(5H)PYRROLONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1995-02-23 | — | — | WO | disclosed |
| WO-1994020467-A1 | NEW 4-AMINOPYRIDINES, PROCESS FOR PREPARING THE SAME AND MEDICAMENTS CONTAINING THE SAME | BOEHRINGER MANNHEIM GMBH (DE) | 1994-09-15 | — | — | WO | disclosed |
| EP-0550576-A1 | PHENYLPYRIDINOL DERIVATIVES AS MEDICAMENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1993-07-14 | — | — | EP | disclosed |
| WO-1992006085-A1 | PHENYLPYRIDINOL DERIVATIVES AS MEDICAMENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1992-04-16 | — | — | WO | disclosed |
| EP-0374789-A1 | 5- Aminoflavone derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-06-27 | — | — | EP | disclosed |
| EP-0328669-A1 | CHALCONE DERIVATIVE COMPOUNDS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-08-23 | — | — | EP | disclosed |
| US-4405626-A | TRANQUILIZERS, HYPOTENSIVE AGENTS; DIURETICS; VISION DEFECTS | PFIZER INC. (US) | 1983-09-20 | — | — | US | disclosed |
| US-4400385-A | TRANQUILIZERS, HYPOTENSIVE AGENTS; DIURETICS; VISION DEFECTS | PFIZER INC. (US) | 1983-08-23 | — | — | US | disclosed |
| US-4380542-A | ANALGESICS, TRANQUILIZERS | PFIZER (US) | 1983-04-19 | — | — | US | disclosed |
| US-4340737-A | CNS AGENTS, HYPOTENSIVES, DIURETICS AND AGENTS FOR TREATMENT OF GLAUCOMA | PFIZER INC. (US) | 1982-07-20 | — | — | US | disclosed |
| US-4264483-A | AN ACRYLIC MONOMER OR OLIGOMER, PHOTOREACTIVE RESIN, PHOTOINITIATOR, FREE RADICAL INHIBITOR, PIGMENT | WHITTAKER CORPORATION (US) | 1981-04-28 | — | — | US | disclosed |
| US-4260764-A | ANALGESICS, TRANQUILIZERS | PFIZER INC. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4254116-A | ANALGESICS, ANTIDEPRESSANTS, NEUTRALIZING AGENTS | ABBOTT LABORATORIES (US) | 1981-03-03 | — | — | US | disclosed |
| US-4243674-A | HYPOTENSIVE AGENTS; ANALGESICS; ANTISECRETORY AGENTS; ANTIBODY INHIBITORS, AND TRANQUILIZERS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| US-4208471-A | HYDROXY-FUNCITIONAL CYCLIC POLYSILOXANE, GLYCIDYL ACRYLATE OR METHACRYLATE AND 3-ACRYLOYLOXY OR METHACRYLOYOXY-PROPYL-TRIMETHOXYSILANE | THE GILLETTE COMPANY (US) | 1980-06-17 | — | — | US | disclosed |
| US-4182629-A | Photochromic compounds | HELLER HAROLD G (GB) | 1980-01-08 | — | — | US | disclosed |
| US-4145536-A | Photochromic compounds | HELLER HAROLD G | 1979-03-20 | — | — | US | disclosed |
| US-4143139-A | ANALGESICS, HYPOTENSIVES, IMMUNOSUPPRESSANTS, TRANQUILIZERS, ANTISECRETORY, ANTI-ANXIETY | PFIZER INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-4081449-A | ANALGESICS, ANTICONVULSANTS | ABBOTT LABORATORIES (US) | 1978-03-28 | — | — | US | disclosed |
| US-4049653-A | ANALGESICS, ANTIANXIETY AGENTS | ABBOTT LABORATORIES (US) | 1977-09-20 | — | — | US | disclosed |
| US-4029665-A | ANTICONVULSANTS | ABBOTT LABORATORIES (US) | 1977-06-14 | — | — | US | disclosed |
| US-4025630-A | Anesthesia methods using benzopyrans and esters thereof as pre-anesthesia medication | ABBOTT LABORATORIES (US) | 1977-05-24 | — | — | US | disclosed |
| US-RE29196-E | ANALGESICS AND TRANQUILIZERS | ABBOTT LABORATORIES (US) | 1977-04-26 | — | — | US | disclosed |
| US-3947462-A | 2,4,7-substituted 5-hydroxy benzopyrans and esters | ABBOTT LABORATORIES (US) | 1976-03-30 | — | — | US | disclosed |
| US-3932432-A | Alkylphenyl benzopyranopyridines | ABBOTT LABORATORIES (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931232-A | 3-Alkyl xanthene compounds | SMITHKLINE CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931232-A | 3-Alkyl xanthene compounds | SMITHKLINE CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325962-A1 | TYROSINE DERIVATIVE | VCAM1, ICAM1, ITGB4 | MAPK1 996/4885MEN1 3425/4885KMT2A 1225/4885 |
| US-20130267509-A1 | THIAZOLE DERIVATIVES | THRA, CHD8, CYP2C8 | MAPK1 4010/4885MEN1 1954/4885KMT2A 992/4885 |
| US-20040087594-A1 | Diaminothiazoles having antiproliferative activity | CDK4, CDK2, CDKL4 | MAPK1 625/4885MEN1 2126/4885KMT2A 634/4885 |
| US-12492171-B2 | Heterocyclic inhibitors of MCT4 | SLC16A3, SLC16A1, MCTS1 | MAPK1 1871/4885MEN1 1465/4885KMT2A 3137/4885 |
| US-20110112118-A1 | 2,4-Diaminoquinazolines for Spinal Muscular Atrophy | SMN1; SMN2, MUSK, MYO3B | MAPK1 2589/4885MEN1 2282/4885KMT2A 91/4885 |
| US-20150023990-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | IL2, IFNG, IRF3 | MAPK1 2511/4885MEN1 3720/4885KMT2A 2789/4885 |
| US-20160083364-A1 | Phenanthridine Derivatives, Preparation Methods and Uses Thereof | CTNNB1, WNT3A, WNT1 | MAPK1 343/4885MEN1 2930/4885KMT2A 4141/4885 |
| US-11008292-B2 | FGFR4 inhibitor and preparation method and use thereof | FGFR4, FGFR1, FGFR2 | MAPK1 386/4885MEN1 1696/4885KMT2A 2244/4885 |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | MAPK1 1398/4885MEN1 230/4885KMT2A 988/4885 |
| US-20160152577-A1 | 2,4-Diaminoquinazolines for Spinal Muscular Atrophy | SMN1; SMN2, MUSK, MYO3B | MAPK1 2589/4885MEN1 2282/4885KMT2A 91/4885 |
| US-20040254149-A1 | 3, 4-Methylenedioxy-substituted chalcones as therapeutic agents | OXER1, CCNO, CCNB3 | MAPK1 480/4885MEN1 3348/4885KMT2A 3077/4885 |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | IL2, IFNG, IRF3 | MAPK1 2511/4885MEN1 3720/4885KMT2A 2789/4885 |
| US-20050288314-A1 | 2,4-diaminoquinazolines for spinal muscular atrophy | SMN1; SMN2, MUSK, MYO3B | MAPK1 2589/4885MEN1 2282/4885KMT2A 91/4885 |
| US-11390578-B2 | Method for synthesizing amines | PNMT, ADH1A, ADH1C | MAPK1 2036/4885MEN1 425/4885KMT2A 162/4885 |
| US-20120135995-A1 | FUNGICIDAL DIPHENYL-SUBSTITUTED PYRIDAZINES | PNPO, CYP1B1, PRXL2A | MAPK1 1658/4885MEN1 2369/4885KMT2A 1537/4885 |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | MAPK1 1392/4885MEN1 3295/4885KMT2A 4267/4885 |
| US-20160039794-A1 | PYRAZOLYLBENZO[D]IMIDAZOLE DERIVATIVES | NR0B2, NR2C2, NR4A3 | MAPK1 2751/4885MEN1 1943/4885KMT2A 1685/4885 |
| US-20070167476-A1 | Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds | IL4, IL2, IL5 | MAPK1 1631/4885MEN1 705/4885KMT2A 2219/4885 |
| US-20170218114-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | EEF1A1, EEF1A2, EEF1E1 | MAPK1 2254/4885MEN1 4250/4885KMT2A 220/4885 |
| US-20020151554-A1 | Diaminothiazoles having antiproliferative activity | CDK4, CDK2, CDKL4 | MAPK1 625/4885MEN1 2126/4885KMT2A 634/4885 |
| US-20160280707-A1 | ALKOXY SUBSTITUTED IMIDAZOQUINOLINES | IL2, IFNG, IRF3 | MAPK1 2511/4885MEN1 3720/4885KMT2A 2789/4885 |
| US-20230043356-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR | AQP1, AQP4, NOTUM | MAPK1 1832/4885MEN1 1826/4885KMT2A 4783/4885 |
| US-20200239496-A1 | Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents | OR10J3, MSRB3, SLC39A3 | MAPK1 1056/4885MEN1 494/4885KMT2A 2298/4885 |
| US-11292767-B2 | Heterocyclic inhibitors of MCT4 | SLC16A3, SLC16A1, MCTS1 | MAPK1 1871/4885MEN1 1465/4885KMT2A 3137/4885 |
| US-20080113994-A1 | Annelated Quinoline Derivatives As Pesticide | DDT, ACHE, SIRT4 | MAPK1 2749/4885MEN1 2151/4885KMT2A 647/4885 |
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | HAAO, HAO2, HAO1 | MAPK1 1505/4885MEN1 4879/4885KMT2A 2644/4885 |
| US-20230025575-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | AOC2, SOD1, AOC3 | MAPK1 1756/4885MEN1 1189/4885KMT2A 224/4885 |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | MAPK1 2105/4885MEN1 4525/4885KMT2A 3324/4885 |
| US-20090081165-A1 | BICYCLIC HETEROARYL DERIVATIVES | HAVCR2, MAVS, ZC3HAV1 | MAPK1 4797/4885MEN1 4832/4885KMT2A 2410/4885 |
| US-20100189795-A1 | CALCIUM SEQUESTRATION COMPOSITIONS AND METHODS OF TREATING SKIN PIGMENTATION DISORDERS AND CONDITIONS | S100A4, TYR, CACYBP | MAPK1 3907/4885MEN1 2378/4885KMT2A 3288/4885 |
| US-20190112275-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | SLC16A3, SLC16A1, MCTS1 | MAPK1 1871/4885MEN1 1465/4885KMT2A 3137/4885 |
| US-20220251047-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | SLC16A3, SLC16A1, MCTS1 | MAPK1 1871/4885MEN1 1465/4885KMT2A 3137/4885 |
| US-20100256361-A1 | THIAZOLE DERIVATIVES | ADORA2A, ADORA3, ADORA1 | MAPK1 3528/4885MEN1 3563/4885KMT2A 4222/4885 |
| US-20230192749-A1 | PROTECTED FLUORESCENT REAGENT COMPOUNDS | ERCC4, ERCC2, ERCC1 | MAPK1 3932/4885MEN1 2015/4885KMT2A 1933/4885 |
| US-20040259957-A1 | 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents | OXER1, ALK, BCL6 | MAPK1 486/4885MEN1 4087/4885KMT2A 2981/4885 |
| US-20180162822-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | SLC16A3, SLC16A1, MCTS1 | MAPK1 1871/4885MEN1 1465/4885KMT2A 3137/4885 |
| US-20040082595-A1 | Intermediates useful in the preparation of diaminothiazoles | CDK4, CDK2, CDKL4 | MAPK1 458/4885MEN1 1319/4885KMT2A 751/4885 |
| US-20170137385-A1 | ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | MYLK, MYLK2, MYLK3 | MAPK1 343/4885MEN1 2993/4885KMT2A 3722/4885 |
| US-20180044284-A1 | NON-IONIC LOW DIFFUSING PHOTO-ACID GENERATORS | PLG, PPARG, PKLR | MAPK1 586/4885MEN1 4827/4885KMT2A 1672/4885 |
| US-20070105919-A1 | adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders | ADORA2A, ADORA3, ADORA1 | MAPK1 3339/4885MEN1 3769/4885KMT2A 3885/4885 |
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | HAVCR2, ZC3HAV1, SARS1 | MAPK1 4791/4885MEN1 4103/4885KMT2A 2460/4885 |
| US-20080075719-A1 | Method for Augmenting B Cell Depletion | CD22, ITGAM, FCGR3B | MAPK1 4197/4885MEN1 3170/4885KMT2A 2362/4885 |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | MAPK1, MAPK3, MAPK4 | MAPK1 1/4885MEN1 3032/4885KMT2A 1449/4885 |
| US-20100261701-A1 | 8-Substituted isoquinoline derivative and the use thereof | RELA, NFKBIA, NFKB2 | MAPK1 48/4885MEN1 2532/4885KMT2A 637/4885 |
| US-20160002194-A1 | 1 -(DIMETHYLAMINO)ETHYL-SUBSTITUTED 6H-BENZO[C]CHROMEN-6-ONES AGAINST SENILE DEMENTIA | BACE1, PSEN1, PSEN2 | MAPK1 1617/4885MEN1 999/4885KMT2A 1032/4885 |
| US-20130203709-A1 | ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME | BCL2, BCL2L2, BCL6 | MAPK1 3736/4885MEN1 3522/4885KMT2A 1022/4885 |
| US-20210155574-A1 | METHOD FOR SYNTHESIZING AMINES | PNMT, ADH1A, ADH1C | MAPK1 2036/4885MEN1 425/4885KMT2A 162/4885 |
| US-20100028262-A1 | 3,4-METHYLENEDIOXY-SUBSTITUTED CHALCONES AS THERAPEUTIC AGENTS | RB1, BCL3, CCNO | MAPK1 853/4885MEN1 1696/4885KMT2A 2195/4885 |
| US-20090023720-A1 | 2-Amino 1H-Imidazo Ring Systems and Methods | IL2, IL2RA, IL4I1 | MAPK1 2759/4885MEN1 3048/4885KMT2A 1860/4885 |
| US-20160031856-A1 | SUBSTITUTED QUINOXALINES AS FGFR KINASE INHIBITORS | FGFR1, FGFR3, ABL1 | MAPK1 515/4885MEN1 1732/4885KMT2A 708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.